News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,954 Results
Type
Article (20002)
Company Profile (105)
Press Release (184847)
Multimedia
Podcasts (29)
Webinars (9)
Section
Business (64772)
Career Advice (821)
Deals (9178)
Drug Delivery (74)
Drug Development (19821)
Employer Resources (140)
FDA (3453)
Job Trends (6051)
News (97418)
Policy (7273)
Tag
Academia (1533)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (20)
Alliances (17744)
ALS (28)
Alzheimer's disease (556)
Antibody-drug conjugate (ADC) (63)
Approvals (3471)
Artificial intelligence (127)
Autoimmune disease (10)
Automation (9)
Bankruptcy (51)
Best Places to Work (4940)
BIOSECURE Act (12)
Biosimilars (49)
Biotechnology (65)
Bladder cancer (26)
Brain cancer (8)
Breast cancer (92)
Cancer (678)
Cardiovascular disease (67)
Career advice (727)
Career pathing (31)
CAR-T (55)
Cell therapy (154)
Cervical cancer (8)
Clinical research (15101)
Collaboration (385)
Compensation (88)
Complete response letters (7)
COVID-19 (1051)
CRISPR (22)
C-suite (137)
Cystic fibrosis (43)
Data (676)
Decentralized trials (1)
Denatured (21)
Depression (16)
Diabetes (74)
Diagnostics (2393)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (52)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (39)
Earnings (15091)
Editorial (15)
Employer branding (23)
Employer resources (118)
Events (30487)
Executive appointments (409)
FDA (3820)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (371)
Gene editing (41)
Generative AI (14)
Gene therapy (109)
GLP-1 (298)
Government (1367)
Guidances (25)
Healthcare (5079)
Huntington's disease (14)
IgA nephropathy (9)
Immunology and inflammation (27)
Indications (6)
Infectious disease (1113)
Inflammatory bowel disease (59)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (31)
Interviews (116)
IPO (3735)
IRA (16)
Job creations (1311)
Job search strategy (635)
Kidney cancer (1)
Labor market (35)
Layoffs (165)
Leadership (11)
Legal (1205)
Liver cancer (23)
Lung cancer (98)
Lymphoma (57)
Machine learning (1)
Management (42)
Manufacturing (133)
MASH (12)
Medical device (2706)
Medtech (2711)
Mergers & acquisitions (5684)
Metabolic disorders (211)
Multiple sclerosis (40)
NASH (9)
Neurodegenerative disease (28)
Neuropsychiatric disorders (5)
Neuroscience (749)
NextGen: Class of 2025 (2138)
Non-profit (1688)
Now hiring (38)
Obesity (128)
Opinion (95)
Ovarian cancer (23)
Pain (32)
Pancreatic cancer (14)
Parkinson's disease (42)
Partnered (13)
Patents (53)
Patient recruitment (26)
Peanut (15)
People (27302)
Pharmaceutical (25)
Pharmacy benefit managers (1)
Phase I (4531)
Phase II (6296)
Phase III (5864)
Pipeline (346)
Policy (54)
Postmarket research (577)
Preclinical (2590)
Press Release (61)
Prostate cancer (32)
Psychedelics (18)
Radiopharmaceuticals (88)
Rare diseases (126)
Real estate (2561)
Recruiting (54)
Regulatory (5305)
Reports (35)
Research institute (1288)
Resumes & cover letters (106)
Rett syndrome (1)
RNA editing (2)
RSV (28)
Schizophrenia (25)
Series A (74)
Series B (44)
Service/supplier (8)
Sickle cell disease (23)
Special edition (8)
Spinal muscular atrophy (51)
Sponsored (14)
Startups (2021)
State (1)
Stomach cancer (6)
Supply chain (24)
Tariffs (8)
The Weekly (8)
Vaccines (231)
Venture capitalists (29)
Weight loss (88)
Women's health (12)
Worklife (16)
Date
Today (60)
Last 7 days (295)
Last 30 days (914)
Last 365 days (10573)
2025 (3630)
2024 (11654)
2023 (13289)
2022 (16150)
2021 (18202)
2020 (16791)
2019 (15324)
2018 (11072)
2017 (10591)
2016 (10417)
2015 (11177)
2014 (8265)
2013 (7183)
2012 (7610)
2011 (7833)
2010 (7285)
Location
Africa (326)
Alabama (21)
Alaska (4)
Arizona (68)
Arkansas (4)
Asia (11506)
Australia (1998)
California (1858)
Canada (648)
China (148)
Colorado (96)
Connecticut (76)
Delaware (85)
Europe (29936)
Florida (266)
Georgia (56)
Hawaii (1)
Idaho (12)
Illinois (133)
India (18)
Indiana (150)
Iowa (6)
Japan (70)
Kansas (29)
Kentucky (7)
Louisiana (4)
Maine (6)
Maryland (207)
Massachusetts (1497)
Michigan (93)
Minnesota (112)
Mississippi (1)
Missouri (32)
Montana (4)
Nebraska (9)
Nevada (12)
New Hampshire (14)
New Jersey (582)
New Mexico (17)
New York (681)
North Carolina (348)
North Dakota (8)
Northern California (868)
Ohio (70)
Oklahoma (6)
Oregon (17)
Pennsylvania (308)
Puerto Rico (3)
Rhode Island (8)
South America (396)
South Carolina (5)
Southern California (617)
Tennessee (31)
Texas (234)
United States (7214)
Utah (46)
Virginia (47)
Washington D.C. (23)
Washington State (151)
West Virginia (1)
Wisconsin (36)
204,954 Results for "particle sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Global CDMO Agno Pharma Completes Acquisition of Particle Sciences Inc.
Agno Pharma, a US-based, global pharmaceutical contract development and manufacturing organization, announced that it will acquire the Lubrizol Particle Sciences Inc. business.
December 18, 2023
·
2 min read
Press Releases
Particle Dynamics Appoints New Vice President of Sales and Marketing as it Sets Sights on Market Expansion and Rapid Growth
February 17, 2025
·
3 min read
Genetown
Fluent Biosciences announces early access availability of transformative direct-guide capture for single cell analysis for complex CRISPR screening in Particle-templated Instant Partitions (PIPseq-CRISPR)
Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces early access availability of new kits and reagents for direct CRISPR guide capture in particle templated instant partitions (PIPseq-CRISPR).
March 21, 2024
·
1 min read
Press Releases
Seraph 100 Blood Filtration Media May Reduce Tumor-Associated Particles in Blood Samples Drawn From Pancreatic Cancer Patients
February 25, 2025
·
5 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Biotech Beach
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek Biosciences, Inc., a leading cell analysis solutions company, officially announced its Enhanced Small Particle Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
May 20, 2024
·
8 min read
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
Genetown
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting.
May 9, 2024
·
3 min read
Press Releases
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 8, 2024
·
7 min read
Genetown
Particles for Humanity Receives Approval to Begin a Study of PFH-VAP in Humans
Particles for Humanity has received approval from the Institutional Review Board (IRB) at the University of Wisconsin-Madison in the United States to begin a human absorption study of PFH-VAP, a stable form of vitamin A.
December 12, 2023
·
2 min read
1 of 20,496
Next
